Conferences
SUFU 2019: State of the Art Lecture: Imaging in Setting of Neuromodulation, Is it Time to Revisit?
February 28, 2019
SUFU 2019: Urinary TIMP-2 is Significantly Associated with Poor Bladder Compliance and Upper Urinary Tract Damage in Adult Patients with Spina Bifida
February 28, 2019
ASCO GU 2019: Phase II Trial of Pembrolizumab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to BCG
February 28, 2019
SUFU 2019: Voiding Behavior Changes in a Murine Model of Chronic UTI is Correlated to Urinary Bacterial Load and Inflammatory Cytokines/Chemokines
February 27, 2019
SUFU 2019: Purinergic Receptors P2Y12 and A2B Antagonistically Regulate Bladder Function
February 27, 2019
ASCO GU 2019: Final analysis from the NIVOREN GETUG AFU 26 study — Safety and Efficacy of Nivolumab in Metastatic Renal Cell Carcinoma
February 23, 2019
ASCO GU 2019: A Phase II Study CALYPSO: The Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer
February 23, 2019
ASCO GU 2019: Outcomes of Patients with Metastatic Clear Cell RCC Treated with Second Line VEGFR-TKI After First Line Immune Checkpoint Inhibitor
February 23, 2019
ASCO GU 2019: Pembrolizumab in Men With Heavily Treated Metastatic Castration-Resistant Prostate Cancer
February 22, 2019
ASCO GU 2019: Questions and Lessons Moving Forward from CARMENA: Which Treatment First? Surgeon’s Perspective
February 22, 2019
ASCO GU 2019: Questions and Lessons Moving Forward from CARMENA: Which Treatment First? Medical Oncologist’s Perspective
February 21, 2019
ASCO GU 2019: Informing the Decision Using Data Science
February 21, 2019
ASCO GU 2019: Quality Metrics in Kidney Cancer Care
February 21, 2019